Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1-4

• Autori principali: Aimin Yang (Autore), Eric S. H. Lau (Autore), Hongjiang Wu (Autore), Ronald C. W. Ma (Autore), Alice P. S. Kong (Autore), Wing Yee So (Autore), Andrea O. Y. Luk (Autore), Amy W. C. Fu (Autore), Juliana C. N. Chan (Autore), Elaine Chow (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2022-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Type 2 diabetes (T2D)-associated end-stage kidney disease (ESKD) is a global burden, while the renoprotective effects of metformin remain controversial. In a population-based cohort (2002-2018) including 96,643 patients with T2D observed for 0.7 million person-years, we estimated the risk associatio...